Julius Clinical

𝗢𝗻𝗹𝘆 𝗼𝗻𝗲 𝘄𝗲𝗲𝗸 𝗹𝗲𝗳𝘁 𝘂𝗻𝘁𝗶𝗹 𝘁𝗵𝗲 𝘄𝗲𝗯𝗶𝗻𝗮𝗿 "𝗣𝗹𝗮𝘀𝗺𝗮 𝗕𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿𝘀 𝗳𝗼𝗿 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀 𝗮𝗻𝗱 𝗠𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 𝗼𝗳 𝗡𝗲𝘂𝗿𝗼𝗱𝗲𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝘃𝗲 𝗗𝗶𝘀𝗼𝗿𝗱𝗲𝗿𝘀," 𝘀𝗰𝗵𝗲𝗱𝘂𝗹𝗲𝗱 𝗳𝗼𝗿 𝐎𝐜𝐭𝐨𝐛𝐞𝐫 15. In this session, speaker Charlotte Teunissen and host Lieza G. Exalto will delve into the latest advancements and practical applications of plasma biomarkers in neurodegenerative diseases. Don't miss this opportunity to deepen your understanding of cutting-edge research and its clinical implications. Register now: https://lnkd.in/ecEv3a7B

From October 21 - 24, 2024, our colleagues Nurit Novak, Lieza G. Exalto, and Bas Nieuwenhuis will be attending the 𝟮𝟬𝟮𝟰 𝗔𝗻𝗻𝘂𝗮𝗹 𝗡𝗘𝗔𝗟𝗦 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 in Florida. With a strong focus on member initiatives and potential new therapies, the NEALS meeting equips attendees with critical insights on upcoming clinical trials and fosters meaningful collaboration within the ALS community. We invite you to connect with Nurit Novak, Lieza G. Exalto, and Bas Nieuwenhuis at the conference, they're excited to meet you and discuss how we can continue advancing ALS research together. To set-up a meeting, contact Nurit Novak directly.

Next month, from 29-31 October 2024, our team Leyla Kragten-Tabatabaie, Ricard Quingles, Ricard Quingles and Tsong Fang, will be representing Julius Clinical at the 𝗪𝗼𝗿𝗹𝗱 𝗩𝗮𝗰𝗰𝗶𝗻𝗲 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝗘𝘂𝗿𝗼𝗽𝗲, Europe’s leading vaccine event. We’re proud to be a sponsor again and excited to connect with fellow experts, exchange insights, and explore new collaborations. 𝗦𝗽𝗲𝗰𝗶𝗮𝗹 𝗵𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁: On October 31st, Tsong Fang will be presenting on the topic of '𝗥𝗲𝗮𝗹 𝗪𝗼𝗿𝗹𝗱 𝗘𝘃𝗶𝗱𝗲𝗻𝗰𝗲 - 𝗙𝗿𝗼𝗺 𝗦𝗮𝗳𝗲𝘁𝘆 𝘁𝗼 𝗮 𝗣𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹 𝗧𝗼𝗼𝗹 𝗳𝗼𝗿 𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗡𝗲𝘄 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝗮𝗻𝗱 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗛𝗲𝗮𝗹𝘁𝗵 𝗢𝘂𝘁𝗰𝗼𝗺𝗲𝘀'. Don’t miss this opportunity to hear him share valuable insights! If you’re attending, we’d love to meet you! Reach out to Leyla Kragten-Tabatabaie directly to set up a meeting, or feel free to drop by Booth #66.

𝗪𝗼𝗿𝗹𝗱 𝗛𝗲𝗮𝗿𝘁 𝗗𝗮𝘆 𝟮𝟬𝟮𝟰: ❤️ 𝗬𝗘𝗦 | 𝗨𝗦𝗘 ❤️ 𝗙𝗢𝗥 𝗔𝗖𝗧𝗜𝗢𝗡 On this #WorldHeartDay, September 29, we at Julius Clinical stand alongside the global community to raise awareness about cardiovascular health and the steps we can all take to prevent heart disease. With heart disease remaining the leading cause of death worldwide, our commitment to research and clinical trials is stronger than ever. Let’s recommit to our collective goal of reducing the global burden of heart disease. Together, through research, innovation, and awareness, we can make heart disease prevention and treatment more effective and accessible to all.

In just 2 days, the 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝗼𝗳 𝗣𝗮𝗿𝗸𝗶𝗻𝘀𝗼𝗻’𝘀 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 𝗮𝗻𝗱 𝗠𝗼𝘃𝗲𝗺𝗲𝗻𝘁 𝗗𝗶𝘀𝗼𝗿𝗱𝗲𝗿𝘀 kicks off, and we're excited to announce that Nurit Novak and Lieza G. Exalto will be attending. If you’re also attending the congress, don’t hesitate to reach out and set up a meeting. Let’s connect and explore ways we can advance the field together.

Exciting conversations yesterday during our 𝗿𝗼𝘂𝗻𝗱 𝘁𝗮𝗯𝗹𝗲 𝗲𝘃𝗲𝗻𝘁 '𝗗𝗲𝗲𝗽 𝗱𝗶𝘃𝗲 𝗶𝗻𝘁𝗼 𝘁𝗵𝗲 𝗿𝗼𝗹𝗲 𝗼𝗳 𝗱𝗲𝗰𝗲𝗻𝘁𝗿𝗮𝗹𝗶𝘇𝗲𝗱 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹𝘀 𝗶𝗻 𝗘𝗽𝗶𝗹𝗲𝗽𝘀𝘆 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵' chaired by our Scientific Officer Lieza G. Exalto. Grateful for the valuable input from leaders like Jacqueline French, Alexis Arzimanoglou, JayEtta Hecker, Wesley Kerr, Meryl Candor Lozano, Megan Sniecinski, Danny van Weelij, Bree DiVentura, Caitlin Grzeskowiak, and Ilene Penn Miller. Our team, Maria Papakrasa and Lieza G. Exalto Looking forward to continuing these important discussions tomorrow at the 𝗘𝗽𝗶𝗹𝗲𝗽𝘀𝘆 𝗣𝗶𝗽𝗲𝗹𝗶𝗻𝗲 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 in Atlanta. https://lnkd.in/eShQdsGN

This week marks 𝗪𝗼𝗿𝗹𝗱 𝗙𝗧𝗗 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗪𝗲𝗲𝗸, a crucial opportunity to raise awareness about 𝗙𝗿𝗼𝗻𝘁𝗼𝘁𝗲𝗺𝗽𝗼𝗿𝗮𝗹 𝗗𝗲𝗺𝗲𝗻𝘁𝗶𝗮 (𝗙𝗧𝗗), one of the most common forms of dementia under 60. FTD affects behavior, personality, language, and movement, with no current cure or effective treatments. At Julius Clinical, we’re proud to contribute to advancing clinical research in neurology, working towards better treatments and ultimately a cure for conditions like FTD. Let’s continue to support those impacted by FTD and shine a light on the importance of research in finding solutions for this and other neurodegenerative diseases. We're in this Together. #endFTD

𝗩𝗮𝗻𝗰𝗮𝗻𝗰𝘆 𝗮𝗹𝗲𝗿𝘁! We're looking for a 𝗛𝗲𝗮𝗱 𝗼𝗳 𝗔𝗰𝗰𝗼𝘂𝗻𝘁𝗶𝗻𝗴 to lead our finance team. We support global pharmaceutical and biotech companies in clinical research for Neurology, Cardiometabolic & Renal, and Infectious Diseases. Key Responsibilities: - Lead accounting and financial operations across multiple international entities. - Ensure compliance with fiscal regulations, reporting, and internal controls. - Manage audits and external relationships with auditors and tax advisors. - Drive continuous improvement in financial policies and processes. 𝗥𝗲𝗮𝗱𝘆 𝘁𝗼 𝗰𝗼𝗻𝘁𝗿𝗶𝗯𝘂𝘁𝗲 𝘁𝗼 𝗹𝗶𝗳𝗲-𝗰𝗵𝗮𝗻𝗴𝗶𝗻𝗴 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵? 𝗔𝗽𝗽𝗹𝘆 𝘁𝗼𝗱𝗮𝘆! https://lnkd.in/ecb-eE-8

🌍🧠 𝗪𝗼𝗿𝗹𝗱 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿’𝘀 𝗗𝗮𝘆 𝟮𝟬𝟮𝟰: 𝗧𝗶𝗺𝗲 𝘁𝗼 𝗮𝗰𝘁 𝗼𝗻 𝗱𝗲𝗺𝗲𝗻𝘁𝗶𝗮, 𝗧𝗶𝗺𝗲 𝘁𝗼 𝗮𝗰𝘁 𝗼𝗻 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿’𝘀. On September 21st, we join the global community in recognizing 𝗪𝗼𝗿𝗹𝗱 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿’𝘀 𝗗𝗮𝘆, part of 𝗪𝗼𝗿𝗹𝗱 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿’𝘀 𝗠𝗼𝗻𝘁𝗵. This day is dedicated to raising awareness about Alzheimer’s disease and dementia, and supporting the millions of people affected worldwide. At Julius Clinical, we are committed to advancing clinical research that can lead to better treatments and, one day, a cure. Together, we can make a real difference in the lives of those impacted by Alzheimer’s.

𝗝𝗼𝗶𝗻 𝗼𝘂𝗿 𝘄𝗲𝗯𝗶𝗻𝗮𝗿: 𝗣𝗹𝗮𝘀𝗺𝗮 𝗯𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿𝘀 𝗳𝗼𝗿 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀 𝗮𝗻𝗱 𝗺𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 𝗼𝗳 𝗡𝗲𝘂𝗿𝗼𝗱𝗲𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝘃𝗲 𝗱𝗶𝘀𝗼𝗿𝗱𝗲𝗿𝘀. We invite you to join our webinar on "Plasma Biomarkers for Diagnosis and Monitoring of Neurodegenerative Disorders'', scheduled for October 15th. During this webinar, our speaker Charlotte Teunissen and host Lieza G. Exalto will explore the latest advancements and practical applications of plasma biomarkers in the field of neurodegenerative diseases. Topics to be covered: - Plasma biomarkers, including Amyloid, pTau, and NfL - Assessing treatment effects in neurodegenerative diseases - Innovations in diagnostic approaches Don't miss this opportunity to enhance your understanding of cutting-edge research and its clinical implications. Register now: https://lnkd.in/ecEv3a7B